GMAB

Genmab A/S (GMAB), a health care sector security, appears in congressional disclosure records with a narrow footprint: a single member, Josh Gottheimer, accounts for all four disclosed trades on record, spanning from July 2023 through January 2025. The balance of those transactions runs three purchases to one sale, reflecting net buying activity over that roughly eighteen-month window. No bipartisan co-trading clusters have been recorded for this ticker, and no executive-branch officials have disclosed transactions in the security within the same public-record timeframe.